ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2022

[Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect].

Shirin Nkongolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.